Mechanical ventilation: advanced modes and waveforms

[1] [1] [1]

Clinical pearls

Red flags

Phase variables — the building blocks of every mode

Every mechanical ventilation mode is assembled from the same phase variables: what triggers inspiration, what is the control/target variable, what limits the breath, and what cycles inspiration off. Knowing the phase variables lets you decode ANY mode, including proprietary brand-specific ones, instead of memorising marketing names.[1]

Mode-by-mode: how each advanced mode works

Pressure control ventilation (PCV)

PCV is a pressure-targeted, time-cycled mode. The clinician sets an inspiratory pressure above PEEP, an inspiratory time (or I:E ratio), a respiratory rate, PEEP and FiO2. On each breath the ventilator delivers flow to reach the set pressure and holds it constant for the set inspiratory time. Because pressure is the controlled variable, flow is allowed to vary: it rises rapidly to a peak early in inspiration and then decelerates toward zero as the alveolus fills and the gradient between airway and alveolus shrinks. The decelerating flow pattern is the signature waveform of PCV.[1]

The variable consequence is tidal volume: Vt is the area under the flow-time curve and depends on compliance and resistance, so Vt falls if compliance drops (worsening ARDS, pneumothorax, plugging) or rises if compliance improves (recruitment). Vt must be monitored every breath — a sustained fall is an alarm for worsening mechanics, not a ventilator fault. In PC the peak airway pressure EQUALS the plateau pressure because pressure is held constant with no resistive overshoot — a single pressure reading suffices, unlike volume control where an inspiratory-hold is needed.[1]

Advantages of the decelerating flow pattern: more homogeneous gas distribution in lungs with heterogeneous time constants (fast units fill early, slow units continue to fill during the decelerating tail), a lower peak inspiratory pressure for the same mean airway pressure than constant-flow VC, and improved oxygenation from a higher mean airway pressure at equivalent plateau pressure. Disadvantages: no guaranteed Vt (unsafe if compliance is volatile), and tidal volume must be trended continuously.[2]

Pressure support ventilation (PSV) and CPAP

PSV is a pressure-targeted, flow-cycled, patient-triggered mode designed for spontaneously breathing patients — the backbone of weaning. The clinician sets a pressure support level above PEEP, PEEP, FiO2, a flow trigger and a rise time; the patient sets the rate, the inspiratory time (via flow cycling) and the size of each breath (effort plus support). Inspiration cycles off when inspiratory flow decays to a threshold (typically 25 per cent of peak flow, adjustable). The patient controls everything except the magnitude of support.[9]

CPAP (continuous positive airway pressure) is the lowest-support extreme of the same family: a single continuous pressure throughout the respiratory cycle with no added inspiratory support — every breath is the patient own, with PEEP recruiting alveoli and reducing the work imposed by PEEP-deprived lung. CPAP tests the patient intrinsic ability to ventilate and oxygenate; it is the basis of the T-piece / CPAP spontaneous breathing trial.[9]

PSV advantages: maximal synchrony (patient-triggered and cycled), preserved respiratory-muscle conditioning, comfortable, and the natural mode for weaning. The classic weaning trials (Brochard, Esteban) established that PSV and T-piece weaning outperform SIMV for the duration of weaning and the rate of successful extubation.[9][10] Risks: support set too low = fatigue and failed trials; too high = over-assistance, respiratory-muscle atrophy, delayed weaning, and asynchrony (delayed cycling, double triggering). Flow cycling mistimes in obstructive disease (premature cycling from early flow decay) and in circuit leak.[6]

Synchronized intermittent mandatory ventilation (SIMV)

SIMV guarantees a set number of mandatory (machine) breaths per minute while allowing the patient to breathe spontaneously between them; crucially, the ventilator synchronises each mandatory breath to a patient effort within a timing window, so a mandatory breath is not delivered on top of a spontaneous breath (avoiding breath-stacking). Spontaneous breaths between mandatory breaths may be unsupported, pressure-supported, or both.[1]

SIMV was historically popular as a weaning mode (progressively reduce the mandatory rate to wean). Modern evidence has overturned this: both the Brochard and Esteban trials showed SIMV weans patients slower and with more failures than pressure-support or T-piece weaning, because the intermittent mandatory breaths impose variable load on the diaphragm and the patient must still work during the mandatory cycle. SIMV is now rarely used as a weaning strategy; it survives mainly as an initial controlled-support mode or combined with pressure support.[9][10]

Dual-control modes: PRVC, VC+ (adaptive pressure ventilation), AutoFlow

Dual-control modes attempt to deliver the best of volume and pressure control: a guaranteed tidal volume (volume-targeted) delivered with a decelerating, pressure-limited breath (pressure-controlled). They are the modern default on most ICU ventilators.[1]

• PRVC (pressure-regulated volume control): the operator sets a target Vt, RR, inspiratory time, PEEP, FiO2, and an upper pressure alarm limit. The ventilator delivers a test breath, measures compliance, then delivers each subsequent breath in pressure-control form (constant pressure, decelerating flow) at the lowest pressure needed to achieve the target Vt. If Vt drifts off target (compliance or resistance change), the ventilator automatically adjusts the inspiratory pressure breath-by-breath (typically in 1-3 cmH2O steps) to keep Vt on target — but never exceeds the set pressure limit.[1]
• VC+ / APV (adaptive pressure ventilation): the Hamilton name for the same dual-control principle — volume-targeted, pressure-limited, adaptive. The ventilator continuously recalculates the pressure required for the target Vt and adapts.
• AutoFlow (Drager): the volume-control variant that adds decelerating flow and adaptive pressure to a conventional VC breath.

The key advantage: guaranteed Vt with the decelerating-flow benefits (homogeneous distribution, lower peak pressure), and automatic adaptation to changing compliance without clinician intervention. The key danger: if compliance suddenly worsens, the ventilator will increase pressure up to the limit to chase the Vt — potentially delivering injurious pressures. The pressure alarm limit (and plateau/driving pressure) must therefore be set tight and monitored; "set it and forget it" is unsafe.[2]

Adaptive support ventilation (ASV)

ASV is a closed-loop mode: the operator enters only the patient height and sex (to compute predicted body weight) and a target minute ventilation (as a percentage of predicted, typically 100 per cent). Using the measured compliance and resistance each breath, the ventilator computes the rate-tidal-volume combination that delivers the target minute ventilation at the minimum work of breathing (the Otis time-constant optimum), while respecting lung-protection limits (Vt within roughly 4-8 mL/kg PBW, plateau under a safety limit). As the patient breathes spontaneously, ASV automatically reduces mandatory support and shifts toward pressure support; if apnoea occurs, it automatically delivers full controlled ventilation.[5][7]

ASV advantages: a single control to set, automatic weaning as the patient recovers (reduced clinician workload), and built-in lung protection. An RCT in difficult-to-wean patients (Kirakli 2015) found ASV shortened weaning time vs a physician-driven protocol in a selected COPD weaning unit.[7] Limitations: it optimises for work of breathing, not necessarily for oxygenation or driving pressure, and requires an intact feedback loop; it is not a substitute for clinician judgement in severe ARDS.

Neurally adjusted ventilatory assist (NAVA)

NAVA delivers support proportional to the electrical activity of the diaphragm (EAdi), measured by an array of electrodes on a specialised nasogastric tube positioned at the gastro-oesophageal junction opposite the crura. The EAdi is a direct, real-time readout of the neural respiratory drive (brainstem to phrenic nerve to diaphragm), independent of airflow and airway pressure. The clinician sets a NAVA gain (cmH2O per microvolt of EAdi); on each breath, support rises and falls in exact proportion to the neural signal — the patient governs every aspect of every breath.[5]

Because trigger and cycling are neural (not pneumatic), NAVA virtually eliminates the common pneumatic asynchronies: ineffective triggering (missed small efforts), auto-triggering (false breaths from leaks), and delayed cycling. It is the most physiological mode available and is uniquely effective for non-invasive ventilation with large mask leaks, where pneumatic triggers fail.[5][6]

Requirements and limits: an intact respiratory drive and neuromuscular pathway (it fails in high cervical cord injury, phrenic nerve injury, severe neuromuscular disease, or deep sedation), a correctly positioned EAdi catheter (verified by a characteristic waveform), and the cost/complexity of the catheter. A backup pneumatic mode is mandatory in case of catheter displacement.[5]

Proportional assist ventilation (PAV+)

PAV+ amplifies patient effort in proportion to the instantaneous flow and volume the patient generates. The ventilator continuously measures compliance and resistance (from a brief inspiratory-hold or flow-interrupter manoeuvre), computes the patient pressure output via the equation of motion, and delivers a clinician-set percentage of the load (the gain, e.g. 50 per cent means the ventilator does half the elastic and resistive work, the patient does half). A small patient effort yields small support; a large effort yields large support — the patient controls rate, Vt, flow and inspiratory time.[5]

Like NAVA, PAV+ gives near-physiological synchrony and patient-governed breathing. Unlike NAVA, it requires no specialised catheter (it works from standard flow/pressure sensing) but needs a reliable estimate of elastance and resistance (PAV+ uses an iterative auto-tune to estimate them). Its main hazard is "run-away": if elastance is underestimated, the gain can exceed 100 per cent and the ventilator output reinforces itself, causing pressure overshoot and breath-stacking — modern PAV+ has an auto-limit that caps pressure and warns the clinician.[5]

Airway pressure release ventilation (APRV) and Bilevel

APRV applies two levels of CPAP — a high pressure (P-high, typically 25-35 cmH2O) held for a long T-high (commonly 4-6 seconds), with a brief release to a low pressure (P-low, 0-5 cmH2O) for a short T-low (0.4-0.8 seconds). The patient breathes spontaneously throughout — at P-high and during release. The sustained P-high maintains alveolar recruitment and a high mean airway pressure (oxygenation, an open-lung strategy); the release clears CO2; the spontaneous breaths preserve venous return, reduce sedation, and protect the diaphragm.[8]

Bilevel (BiVent, Duo-PAP) is the generalised two-level pressure mode with a more conventional ratio and set mandatory breaths — comfortable and synchronised for patients with some drive who still need a controlled background. APRV is the extreme inverse-ratio form.[8]

Settings and titration: start P-high near the previous plateau pressure; set P-low to 0-5; set the release frequency (10-14/min) and titrate T-low so expiratory flow returns to about 50-75 per cent of peak (a partial release, not a full expiration — full expiration derecruits the lung). Monitor the expiratory flow waveform — it is the single most important adjustment.[8]

Avoid APRV in obstructive disease (asthma, COPD): the sustained high pressure and brief releases worsen dynamic hyperinflation and air-trapping — the opposite of the long-expiration strategy these patients need. A systematic review and meta-analysis found APRV improves oxygenation in ARDS without a clear mortality benefit over conventional lung-protective ventilation; it is not first-line.[8]

High-frequency oscillatory ventilation (HFOV)

HFOV uses an oscillating piston/membrane (the diaphragm in the oscillator circuit) to deliver very small tidal volumes (often less than anatomic dead space, 1-3 mL/kg) at very high frequencies (3-15 Hz, i.e. 180-900 breaths/min) around a sustained high mean airway pressure. Gas exchange occurs by unconventional mechanisms (bulk flow, Taylor dispersion, pendelluft, molecular diffusion, coaxial flow) rather than conventional bulk convection. The high mean airway pressure keeps the lung recruited (open-lung oxygenation), while the tiny tidal volumes minimise volutrauma.[2]

Settings: mean airway pressure (mPaw, ~25-35 cmH2O — the recruitment/oxygenation variable), power/amplitude (delta-P, the oscillation magnitude — the CO2 clearance variable), frequency (Hz — lower frequency = larger effective tidal volume and better CO2 clearance), inspiratory time percentage, and FiO2. A common pitfall is using too high a frequency, which shrinks tidal volume and causes CO2 retention.[3]

The evidence turned HFOV from promising to near-abandoned in adult ARDS: two large multicentre RCTs published in the same 2013 NEJM issue (OSCILLATE and OSCAR) failed to show benefit. OSCILLATE (Ferguson) was stopped early because HFOV increased in-hospital mortality (47 per cent vs 35 per cent) — driven by heavy sedation, paralysis, and haemodynamic compromise from the high intrathoracic pressure. OSCAR (Young) found no mortality difference. HFOV is now reserved for select rescue scenarios (severe refractory hypoxaemia failing proning and optimised conventional ventilation) and is not standard for adult ARDS.[3][4]

Master comparison: all advanced modes at a glance

[1]

Decelerating (PC) vs constant (VC) flow — the waveform signature

How dual-control modes adapt — breath by breath

How NAVA works

How PAV+ works

How ASV works

HFOV — setup, titration and weaning

Waveform-based troubleshooting at the bedside

Choosing the mode — match the mode to the patient

Evidence — the landmark trials

[1]

More clinical pearls

Red flags (additional)

References

1. [1]Chatburn RL, El-Khatib M, Mireles-Cabodevila E A taxonomy for mechanical ventilation: 10 fundamental maxims Respir Care, 2014.PMID 25118309
2. [2]Slutsky AS, Ranieri VM Ventilator-induced lung injury N Engl J Med, 2013.PMID 24283226
3. [3]Ferguson ND, Cook DJ, Guyatt GH, et al. High-frequency oscillation in early acute respiratory distress syndrome N Engl J Med, 2013.PMID 23339639
4. [4]Young D, Lamb SE, Shah S, et al. High-frequency oscillation for acute respiratory distress syndrome N Engl J Med, 2013.PMID 23339638
5. [5]Vaporidi K, Akoumianaki E, Georgopoulos D NAVA and PAV+ for lung and diaphragm protection Curr Opin Crit Care, 2020.PMID 31738231
6. [6]Mirabella L, Cinnella G, Costa R Patient-Ventilator Asynchronies: Clinical Implications and Practical Solutions Respir Care, 2020.PMID 32665426
7. [7]Kirakli C, Naz I, Ediboglu O A randomized controlled trial comparing the ventilation duration between adaptive support ventilation and pressure assist/control ventilation in medical patients in the ICU Chest, 2015.PMID 25742308
8. [8]Patel R, Thompson J, et al. Safety, Efficacy, and Clinical Outcomes of APRV in ARDS: A Systematic Review and Meta-Analysis J Intensive Care Med, 2026.PMID 42033378
9. [9]Brochard L, Rauss A, Benito S, et al. Comparison of three methods of gradual withdrawal from ventilatory support during weaning from mechanical ventilation Am J Respir Crit Care Med, 1994.PMID 7921460
10. [10]Esteban A, Frutos F, Tobin MJ, et al. A comparison of four methods of weaning patients from mechanical ventilation. Spanish Lung Failure Collaborative Group N Engl J Med, 1995.PMID 7823995